CBD protected rat hearts from ischemia-reperfusion injury by activating a mitochondrial biogenesis pathway (SIRT-1/PGC-1α) and suppressing inflammatory and cell-death signals.
Cardiologists following cannabinoid research, CBD researchers, and people interested in heart health and mitochondrial medicine
What the researchers found
Prophylactic CBD treatment restored myocardial architecture, suppressed inflammatory and apoptotic responses, and enhanced mitochondrial biogenesis through SIRT-1/PGC-1α activation in a rat heart attack model, with therapeutic CBD providing partial protection.
Why it matters
Heart attacks cause damage not just from blocked blood flow but also when flow returns (reperfusion injury) — CBD's ability to protect against this 'double hit' could improve cardiac outcomes.
The numbers in context
40 rats across 4 groups; 30-minute ischemia + 30-minute reperfusion model; prophylactic CBD significantly restored SIRT-1, PGC-1α, and Bcl-2 expression while reducing NF-κB and VCAM-1.
How the study worked
Controlled preclinical study with 40 rats in 4 groups (sham, I/R, prophylactic CBD, therapeutic CBD), inducing heart attack by 30-min coronary artery ligation followed by 30-min reperfusion, with histological, biochemical, and genetic analysis.
What this study cannot tell us
Acute rat model; prophylactic administration is more protective than therapeutic, which limits practical clinical application; specific CBD doses not detailed in abstract.
How to read the evidence
Well-designed preclinical study with comprehensive molecular analysis, but animal model with acute timeframe limits clinical translation.
When this study was published
Published in 2026, adding to the growing body of CBD cardioprotection research.
The bigger picture
The SIRT-1/PGC-1α pathway is a master regulator of mitochondrial health — CBD's activation of this pathway suggests cardioprotection through fundamental cellular energy mechanisms rather than surface-level symptom management.
Questions still open
- What is the optimal timing window for CBD cardioprotection relative to ischemic events? Could CBD serve as an adjunct therapy during cardiac procedures?
Common questions
Can CBD protect the heart during a heart attack?
What is ischemia-reperfusion injury?
Read the original research
Cannabidiol Protects the Heart from Ischemia-Reperfusion Injury Through SIRT-1/PGC-1α Activation and NF-κB Modulation: Experimental Insights.
Journal of cardiovascular pharmacology
Citation
Aksoy, Fatih; Savran, Mehtap; Uysal, Dincer; Bagci, Ali; Ilhan, Ilter; Imeci, Orhan; Sevuk, Mehmet A; Ozmen, Ozlem; Tepebasi, Muhammet Y; Asci, Halil. (2026). Cannabidiol Protects the Heart from Ischemia-Reperfusion Injury Through SIRT-1/PGC-1α Activation and NF-κB Modulation: Experimental Insights.. Journal of cardiovascular pharmacology. https://doi.org/10.1097/FJC.0000000000001806
Explore the wider topic
- CBD Oil Quality Guide: How to Avoid Snake Oil
- Anxiety After Quitting Weed: When to Consider Medication
- Cannabis for Chemotherapy Nausea: What the Evidence Actually Shows
- Cannabis for Chronic Pain: What the Research Actually Supports
- Cannabis and Epilepsy: The Epidiolex Story and What It Means
- Does CBD Actually Work for Anxiety? What the Evidence Shows
- Does CBD Help with Weed Withdrawal? What Studies Show
- CBD vs THC: The Differences That Actually Matter
- The Proven Medical Benefits of Cannabis: What Research Supports
- Quitting Weed Before Surgery
- Weed and Medications: What Changes When You Quit
- Quitting Weed During Pregnancy: What You Need to Know
- Quitting Weed While Pregnant: What You Need to Know
- Cannabis and Older Adults: Risks Seniors Should Know
- Cannabis and Breastfeeding: THC in Breast Milk